HomeTagsMining

mining

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Vietnam’s Massive Economic Boom Saves Jardine Cycle & Carriage’s FY2025

https://open.spotify.com/episode/3k6XGAsQgKCELTMuXKoCOB?si=930ffe0ca97f4309 The Art of the Regional Hedge: How Jardine Cycle & Carriage Navigated the Southeast...
SGX-LISTED COMPANIES

500% Profit Surge – How Fortress Minerals Is Defying Global Steel Headwinds In Q3 FY2026

The global steel industry is currently navigating a period of significant contraction. Between January...
SGX-LISTED COMPANIES

$100M Locked Away. Alita Resources Survives On Frozen Cash After Half-Year Ended December 2024

4 Shocking Truths About a Company in Limbo In the world of corporate finance, some...
SGX-LISTED COMPANIES

Fortress Minerals Sees Revenue Rise But Profits Slashed In Q2 FY2026

Sales Are Up, Profits Are Down: The Surprising Story Hidden in a Mining Company's...
SGX-LISTED COMPANIES

Southern Alliance Mining’s FY2025 Loss Skyrockets 1,157%

This Mining Company's Revenue Grew 20%, But Losses Exploded Over 1,000%. Here’s What’s Really...

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...